BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 2, 2007
View Archived Issues
Series A And B Rounds Up As Early Stage Model Evolves
Of the $2.1 billion in venture capital invested in global biotechnology companies last quarter, the majority went into earlier-stage financings, according to data from BioWorld Financial Watch and BioWorld Snapshots. (BioWorld Today)
Read More
House Hearing Probes Range Of Ways To Improve The FDA
Read More
Optimer's CDAD Drug Starts Second Pivotal Phase III Trial
Read More
NewCo News: Start-Up Solace Raises $15M In Series A For Pain Drugs
Read More
Italian Firm Eurand Files For IPO On Nasdaq Of Up To $153M
Read More
Other News To Note
Read More
Clinic Roundup
Read More